Please provide your email address to receive an email when new articles are posted on . Patients who viewed a multimedia presentation before cataract surgery demonstrated better understanding of the ...

ALISO VIEJO, Calif. , April 19, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST)-- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, ...

To review the current management and outcomes of retinal detachment following cataract surgery in childhood. In 37% of patients, the fellow eye was blind (<3/60). The macula was detached at ...

Aim The aim of the study was to identify variations in cataract presentation within three different eye units in a single health authority and to identify any correlation between cataract presentation ...

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment ...

Dr. Andrew Esposito, a cornea and refractive surgeon for the Cleveland Clinic Cole Eye Institute, will offer a presentation about cataracts and choices that are now available for restoration of vision ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today ...

Dr. Thomas Kropp will present a program, “Focusing on Cataracts,” at 7 p.m. Thursday at West Volusia Memorial Hospital, DeLand. Included in the free community health awareness program will be a ...

MENLO PARK, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve ...

MONTEREY, Calif. — A study conducted at the Children’s Mercy Hospital in Kansas City examined the outcomes of surgical intervention in infants with delayed-presentation unilateral juvenile cataract ...

Session title: Ocular Surface Disease Presentation Date: Saturday, May 6, 2023 Session time: 3:30 PM-5:00 PMASCRS Paper ID 92218 Paper Title: OK-101, a Novel Chemerin Receptor Agonist, Decreased ...

HEIDELBERG, Germany & CAMBRIDGE, Mass.--(BUSINESS WIRE)--#cyclasol--Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free ...